***** TODAY’S NEWS New experimental RA/Lupus drug suspended after patient deaths - Swiss drugmaker Roche Holding AG and U.S. biotechnology company Biogen Idec are suspending rheumatoid arthritis …
Impactiviti Daily 102510
TODAY’S NEWS Pfizer's oncology drug Sutent slows down pancreatic cancer spread - Pfizer Inc. said Sutent, its drug for kidney cancer, also helps stop the progression of a kind of pancreatic cancer, …
Today’s Top News in Pharma 070109
Strangest Indication of the Year Award: first drug I've seen with a directional indication - Cephalon, Inc. today announced that it has submitted a supplemental New Drug Application (sNDA) to the U.S. …
Today’s Top Three in Pharma 060209
Sepracor's experimental epilepsy drug (Stedesa) proceeds to FDA review. STEDESA, a new chemical entity, is a novel voltage-gated sodium channel blocker. STEDESA has been studied in three Phase …
Pharma News this week (and last)
Roche's MabThera can help extend CLL patients' lives. Meanwhile, surprisingly good results for AZ's lung cancer drug Iressa. But, disappointment for an experimental lung cancer drug being developed by …
August ’08 Pharma News
The Xa factor: not looking so promising for Pfizer and Bristol - Bristol-Myers Squibb and Pfizer's apixaban blood clot preventer raised rates of bleeding in a 6-month study but showed some encouraging …